These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16736128)

  • 1. The release of the adipocytokine visfatin is regulated by glucose and insulin.
    Haider DG; Schaller G; Kapiotis S; Maier C; Luger A; Wolzt M
    Diabetologia; 2006 Aug; 49(8):1909-14. PubMed ID: 16736128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma ghrelin concentrations are not regulated by glucose or insulin: a double-blind, placebo-controlled crossover clamp study.
    Schaller G; Schmidt A; Pleiner J; Woloszczuk W; Wolzt M; Luger A
    Diabetes; 2003 Jan; 52(1):16-20. PubMed ID: 12502488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free fatty acids normalize a rosiglitazone-induced visfatin release.
    Haider DG; Mittermayer F; Schaller G; Artwohl M; Baumgartner-Parzer SM; Prager G; Roden M; Wolzt M
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E885-90. PubMed ID: 16735449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1).
    Bala M; Martin J; Kopp A; Hanses F; Buechler C; Schäffler A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2493-501. PubMed ID: 21677044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on: Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M (2006) the release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49:1909-1914.
    Pfützner A; Forst T
    Diabetologia; 2006 Nov; 49(11):2795; author reply 2796. PubMed ID: 16917757
    [No Abstract]   [Full Text] [Related]  

  • 6. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans.
    Marcinkowska M; Lewandowski KC; Lewiński A; Bieńkiewicz M; Basińska-Lewandowska M; Salata I; Randeva HS
    Endokrynol Pol; 2007; 58(3):188-94. PubMed ID: 17940983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fatty acid regulation on visfatin gene expression in adipocytes.
    Wen Y; Wang HW; Wu J; Lu HL; Hu XF; Cianflone K
    Chin Med J (Engl); 2006 Oct; 119(20):1701-8. PubMed ID: 17097017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes.
    McGee KC; Harte AL; da Silva NF; Al-Daghri N; Creely SJ; Kusminski CM; Tripathi G; Levick PL; Khanolkar M; Evans M; Chittari MV; Patel V; Kumar S; McTernan PG
    PLoS One; 2011; 6(6):e20287. PubMed ID: 21694775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.
    Fukuhara A; Matsuda M; Nishizawa M; Segawa K; Tanaka M; Kishimoto K; Matsuki Y; Murakami M; Ichisaka T; Murakami H; Watanabe E; Takagi T; Akiyoshi M; Ohtsubo T; Kihara S; Yamashita S; Makishima M; Funahashi T; Yamanaka S; Hiramatsu R; Matsuzawa Y; Shimomura I
    Science; 2005 Jan; 307(5708):426-30. PubMed ID: 15604363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term regulation of Visfatin release in vivo by oral lipid ingestion and in vitro by fatty acid stimulation.
    Karrasch T; Leszczak S; Bala M; Ober I; Martin J; Schmid A; Kopp A; Schaffler A
    Exp Clin Endocrinol Diabetes; 2014 Feb; 122(2):126-34. PubMed ID: 24554513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes.
    Kralisch S; Klein J; Lossner U; Bluher M; Paschke R; Stumvoll M; Fasshauer M
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E586-90. PubMed ID: 15899942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes.
    Kralisch S; Klein J; Lossner U; Bluher M; Paschke R; Stumvoll M; Fasshauer M
    J Endocrinol; 2005 Jun; 185(3):R1-8. PubMed ID: 15930160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.
    Haider DG; Schindler K; Mittermayer F; Müller M; Nowotny P; Rieger A; Luger A; Ludvik B; Wolzt M
    Clin Pharmacol Ther; 2007 Apr; 81(4):580-5. PubMed ID: 17235334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.
    Lewandowski KC; Stojanovic N; Press M; Tuck SM; Szosland K; Bienkiewicz M; Vatish M; Lewinski A; Prelevic GM; Randeva HS
    Diabetologia; 2007 May; 50(5):1033-7. PubMed ID: 17334748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial.
    Gögebakan Ö; Osterhoff MA; Schüler R; Pivovarova O; Kruse M; Seltmann AC; Mosig AS; Rudovich N; Nauck M; Pfeiffer AF
    Diabetologia; 2015 Aug; 58(8):1759-68. PubMed ID: 25994074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats.
    Lv Q; Wang Y; Wang W; Wang L; Zhou X
    Endocr Res; 2009; 34(4):130-41. PubMed ID: 19878073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 upregulates visfatin expression in 3T3-L1 adipocytes.
    Liu R; Ding X; Wang Y; Wang M; Peng Y
    Horm Metab Res; 2013 Sep; 45(9):646-51. PubMed ID: 23670349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.